Tabula Rasa HealthCare Inc (TRHC) Receives $82.27 Consensus Target Price from Analysts

Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) have earned an average rating of “Buy” from the fourteen brokerages that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $82.27.

Several research analysts have recently commented on the company. Cantor Fitzgerald reissued a “buy” rating and issued a $99.00 target price on shares of Tabula Rasa HealthCare in a report on Tuesday, November 6th. Zacks Investment Research raised Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Thursday, December 6th. Piper Jaffray Companies reissued an “overweight” rating and issued a $80.00 target price on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. BidaskClub downgraded Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. Finally, Chardan Capital boosted their target price on Tabula Rasa HealthCare from $77.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, November 7th.

In other news, President Orsula V. Knowlton acquired 7,500 shares of Tabula Rasa HealthCare stock in a transaction on Monday, November 12th. The shares were purchased at an average price of $65.00 per share, with a total value of $487,500.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction on Wednesday, October 17th. The stock was sold at an average price of $81.01, for a total value of $648,080.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 63,790 shares of company stock worth $4,409,251. Company insiders own 14.00% of the company’s stock.

Large investors have recently bought and sold shares of the business. Citadel Advisors LLC lifted its holdings in Tabula Rasa HealthCare by 47.0% during the 2nd quarter. Citadel Advisors LLC now owns 8,855 shares of the company’s stock worth $565,000 after buying an additional 2,832 shares in the last quarter. BlackRock Inc. lifted its holdings in Tabula Rasa HealthCare by 29.7% during the 2nd quarter. BlackRock Inc. now owns 2,119,507 shares of the company’s stock worth $135,288,000 after buying an additional 484,979 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in Tabula Rasa HealthCare by 43.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 35,800 shares of the company’s stock worth $2,286,000 after buying an additional 10,900 shares in the last quarter. WINTON GROUP Ltd acquired a new position in Tabula Rasa HealthCare during the 3rd quarter worth $535,000. Finally, Metropolitan Life Insurance Co. NY lifted its holdings in Tabula Rasa HealthCare by 63.6% during the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 5,770 shares of the company’s stock worth $368,000 after buying an additional 2,243 shares in the last quarter. 74.87% of the stock is currently owned by hedge funds and other institutional investors.

TRHC stock opened at $66.00 on Friday. Tabula Rasa HealthCare has a 1-year low of $28.55 and a 1-year high of $91.16. The company has a market capitalization of $1.35 billion, a PE ratio of -1,650.00, a P/E/G ratio of 4.20 and a beta of 2.45. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.46 and a current ratio of 0.49.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its earnings results on Tuesday, November 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.19 by $0.07. The business had revenue of $54.42 million for the quarter, compared to the consensus estimate of $52.87 million. Tabula Rasa HealthCare had a positive return on equity of 7.63% and a negative net margin of 13.49%. Tabula Rasa HealthCare’s revenue was up 66.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.08 EPS. Analysts forecast that Tabula Rasa HealthCare will post 0.42 earnings per share for the current year.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Read More: Bull Market

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply